Commentary on Unexpected Fentanyl Detection during a Liver Transplant Evaluation
Open Access
- 1 March 2023
- journal article
- editorial
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 69 (3) , 225-226
Abstract
This case highlights the potential consequences that false-positive (FP) urine drug screen (UDS) results can have on patient care and reinforces the need to confirm preliminary screen results with a direct method, such as liquid chromatography–tandem mass spectrometry (LC-MS/MS). Rather than act on the unexpected results, the transplant team appropriately consulted the laboratory and confirmatory testing was performed. Neither fentanyl or norfentanyl were detected on the LC-MS/MS confirmation assay, meaning the immunoassay screen result was a FP.Keywords
This publication has 2 references indexed in Scilit:
- Discovering Cross-Reactivity in Urine Drug Screening Immunoassays through Large-Scale Analysis of Electronic Health RecordsClinical Chemistry, 2019
- False-Positive Interferences of Common Urine Drug Screen Immunoassays: A ReviewJournal of Analytical Toxicology, 2014